PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.\', \'Department of Infectious Diseases, Chiba University Hospital, Chiba, Japan; Chiba University Hospital COVID-19 Vaccine Center, Chiba, Japan.\', \'Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan.\', \'Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Chiba University Hospital COVID-19 Vaccine Center, Chiba, Japan. Electronic address: nakajimh@faculty.chiba-u.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(22)00192-X10.1016/j.vaccine.2022.02.045
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35241300
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35241300>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35241300>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all